Hepatitis B and Hepatitis C - Seroprevalence and Correlation with C-Reactive Protein
Authors/Creators
- 1. Department of Microbiology, Gajra Raja Medical College, Gwalior, Madhya Pradesh, India
- 2. Department of Obstetrics and Gynaecology, Gajra Raja Medical College, Gwalior, Madhya Pradesh, India
Description
Background: Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. Materials and Methods: Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. Results: The seroprevalence of HBV and HCV in our study samples was found to be 6.3% and 2.3% respectively. CRP levels were found to be raised in both HBV and HCV positive samples. Conclusion: Viral hepatitis caused by HBV and HCV continues to pose a threat as a significant health problem. Emphasis should be put on health education of the general and high-risk populations, along with health care workers to increase knowledge on preventive measures for these infections.
Abstract (English)
Background: Viral hepatitis caused by Hepatitis B(HBV) and Hepatitis C virus (HCV) is a major public health problem specially in developing countries like India. Materials and Methods: Three hundred blood samples were collected from patients having clinical sign and symptoms of hepatitis and apparently healthy pregnant females. Detection of hepatitis B surface antigen, antibodies against hepatitis C virus and C reactive protein (CRP) was done in these samples. Results: The seroprevalence of HBV and HCV in our study samples was found to be 6.3% and 2.3% respectively. CRP levels were found to be raised in both HBV and HCV positive samples. Conclusion: Viral hepatitis caused by HBV and HCV continues to pose a threat as a significant health problem. Emphasis should be put on health education of the general and high-risk populations, along with health care workers to increase knowledge on preventive measures for these infections.
Files
IJPCR,Vol15,Issue6,Article260.pdf
Files
(343.6 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:a740c8290ff632def587bff16838d481
|
343.6 kB | Preview Download |
Additional details
Dates
- Accepted
-
2023-05-05
Software
- Repository URL
- https://impactfactor.org/PDF/IJPCR/15/IJPCR,Vol15,Issue6,Article260.pdf
- Development Status
- Active
References
- 1. World Health Organization. Global health sector strategy on viral hepatitis, 2016–2021.Towards ending viral hepatitis [Internet]. World Health Organization; 2016. 2. Progress report on HIV, viral hepatitis and sexually transmitted infections 2021: accountability for the global health sector strategies, 2016–2021: actions for impact. Geneva: World Health Organization; 2021 3. 3.Steven Specter, Richard L. Hodnka, Stephen A. Young, Danny L. Wiedbrauk. Blood borne Hepatitis Viruses: Hepatitis Viruses B, C & D and candidate agents of Cryptogenetic Hepatitis. Chapter 21, Fourth Edition, Clinical Virology Manual. 4. 4.Guidelines for the screening care and treatment of persons with chronic hepatitis C infection. WHO. 2016. 5. Sproston NR, Ashworth JJ. Role of CReactive Protein at Sites of Inflammation and Infection. Front Immunol. 2018; 9:754. 6. Jiang SJ, Tsai PI, Peng SY, Chang CC, Chung Y, Tsao HH, et al. A potential peptide derived from cytokine receptors can bind proinflammatory cytokines as a therapeutic strategy for anti-inflammation. Sci Rep. 2019;9(1):2317. 7. Hao S, Wang Y, Gao G, Li Z. Hepatitis B Virus Upregulates the Expression of C-reactive Protein Bothin vivo and in vitro. Ann Clin Lab Sci. 2017 Aug;47(4):432-435. 8. Shah, S.; Ma, Y.; Scherzer, R.; Huhn, G.; French, A.L.; Plankey, M.; Peters, M.G.; Grunfeld, C.; Tien, P.C. Association of HIV, hepatitis C virus and liver fibrosis severity with interleukin-6 and C-reactive protein levels. AIDS. 2015; 29: 1325–1333. 9. Popovic, L.; Maja, J.; Miodrag, V.; Ljiljana, K.; Velimir, K.; Ivan, D. High sensitivity C-reactive protein as prediction factor of disease progression in patients with chronic hepatitis C and mild liver steatosis. Acta Med. 2010; 49: 14–18. 10. National Program for Surveillance of Viral Hepatitis. Seroprevalence of Hepatitis B and Hepatitis C (Based on National Family Health Survey-4). Factsheet 2021. 11. Khan F, Shams S, Qureshi ID, Israr M, Khan H, Sarwar MT, Ilyas M. Hepatitis B virus infection among different sex and age groups in Pakistani Punjab. Virol J. 2011 May 13; 8:225. 12. Sibia P, Mohi MK, Kumar A. Seroprevalence of Hepatitis B Infection among Pregnant Women in One of the Institute of Northern India. J Clin Diagn Res. 2016 Aug;10(8): QC08-9. 13. Goyal LD, Kaur S, Jindal N, Kaur H. HCV and pregnancy: prevalence, risk factors, and pregnancy outcome in north Indian population: a case-control study. J Obstet Gynaecol India. 2014 Oct;64(5):332-6. 14. Desikan P, Khan Z. Prevalence of hepatitis B and hepatitis C virus coinfection in India: A systematic review and meta-analysis. Indian J Med Microbiol. 2017 Jul-Sep;35(3):332- 339. 15. 15.Singh S, Bansal A, Kumar P. CRP Levels in Viral Hepatitis: A MetaAnalysis Study. Int J Infect. 2021; 8(1):e108958. 16. Moura TCF, Amoras EDSG, Queiroz MAF, Conde SRSDS, Grisólia ABA, Ishak R, Vallinoto ACR. Association of serum levels of C-reactive protein with CRP-717 T/C polymorphism and viremia in HCV and HBV carriers. Rev Soc Bras Med Trop. 2019 Feb 21;52: e20180455. 17. Bhuiyan AR, Mitra AK, Ogungbe O, Kabir N. Association of HCV Infection with C-Reactive Protein: National Health and Nutrition Examination Survey (NHANES), 2009⁻2010. Diseases. 2019 Feb 24;7(1):25.